Serum levels of Adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Bao, Yuqian ^a   Lu, Zhigang ^a   Zhou, Mi ^a,b   Li, Huating ^a,b   Wang, Ye ^a,b   Gao, Meifang ^a   Wei, Meng ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; ASIAN; BLOOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; REGRESSION ANALYSIS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REGRESSION ANALYSIS;

EID: 79955737334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019115     Document Type: Article

References (36)

1. Kershaw EE, Flier JS, (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556.
2. Makowski L, Hotamisligil GS, (2004) Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 134: 2464S-2468S.
3. Boord JB, Fazio S, Linton MF, (2002) Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13: 141-147.
4. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379.
5. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS, (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396.
6. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, et al. (2008) Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118: 2640-2650.
7. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Med 7: 699-705.
8. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, et al. (2002) Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 22: 1686-1691.
9. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959-965.
10. Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, et al. (2006) A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A 103: 6970-6975.
11. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, et al. (2006) Adipocyte fatty acid-binding protein is a plasmabiomarker closely associated with obesity and metabolic syndrome. Clin Chem 52: 405-413.
12. Yeung DCY, Xu A, Cheung CWS, Wat NMS, Yau MH, et al. (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis in Chinese women. Arterioscler Thromb Vasc Biol 27: 1796-1802.
13. Rhee EJ, Lee WY, Park CY, Oh KW, Kim BJ, et al. (2009) The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 160: 165-172.
14. Jin J, Peng DQ, Yuan SG, Zhao SP, Ning XH, et al. (2010) Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clin Chim Acta 411: 1761-1765.
15. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
16. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults (2007) [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi 35: 390-419.
17. Judkins MP, (1968) Percutaneous transfemoral selective coronary arteriography. Radiol Clin North Am 6: 467-492.
18. Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, et al. (1981) Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64: 1174-1184.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
20. Cockcroft DW, Gault MH, (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
21. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, et al. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 115: 1537-1543.
22. Tso AW, Xu A, Sham PC, Wat NM, Wang Y, et al. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30: 2667-2672.
23. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, et al. (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1: 107-119.
24. Furuhashi M, Hotamisligil GS, (2008) Fatty acid-binding proteins: role in metabloic diseases and potential as drug targets. Nat Rev Drug Discov 7: 489-503.
25. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716.
26. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS, (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. J Biol Chem 280: 12888-12895.
27. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK, (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
28. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P, (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9: 213-219.
29. Miyoshi T, Onoue G, Hirohata A, Hirohata S, Usui S, et al. (2010) Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211: 164-169.
30. Goetze JP, (2004) Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 50: 1503-1510.
31. Struthers AD, Davies J, (2005) B-type natriuretic peptide: a simple new test to identify coronary artery disease? QJM 98: 765-769.
32. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, et al. (2009) Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105: 326-334.
33. Ridker PM, (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369.
34. Pasceri V, Willerson JT, Yeh ET, (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165-2168.
35. Devaraj S, Xu DY, Jialal I, (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107: 398-404.
36. Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lossner U, et al. (2008) Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf) 69: 901-905.